Buchumschlag

Chronic Δ9‐tetrahydrocannabinol exposure during adolescence is associated with persistent behavioural tolerance in adult nonhuman primates

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Yasaman Razavi, Stephen J. Kohut, Jack Bergman, Brian D. Kangas
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Population pharmacokinetic modelling revealed large variability in oromucosal absorption of Δ 9 ‐tetrahydrocannabinol in older patients with poor appetite
von: Ida Klitzing Storgaard, et al.
Veröffentlicht: (2025)

Sex‐specific impact of repeated adolescent vapour exposure to JWH‐018 on dopamine response, behaviour and pharmacokinetics across adolescence and adulthood
von: Nicholas Pintori, et al.
Veröffentlicht: (2025)

Chronic stress induces behavioural changes through increased kynurenic acid by downregulation of kynurenine‐3‐monooxygenase with microglial decline
von: Masaya Hasegawa, et al.
Veröffentlicht: (2024)

ST‐2560, a selective inhibitor of the NaV1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non‐human primates
von: John V. Mulcahy, et al.
Veröffentlicht: (2024)

Cabotegravir PopPK analysis of adults and adolescents living with HIV/at risk for HIV receiving prep
Veröffentlicht: (2024)

A pH‐sensitive opioid does not exhibit analgesic tolerance in a mouse model of colonic inflammation
von: Claudius E. Degro, et al.
Veröffentlicht: (2024)

Transient receptor potential ankyrin 1 channel modulates the abuse‐related mechanisms of methamphetamine through interaction with dopamine transporter
von: Kwang‐Hyun Hur, et al.
Veröffentlicht: (2024)

A procedure to identify persistent and effort‐independent individual differences in preference for heroin over rewarding social interaction
von: Ginevra D'Ottavio, et al.
Veröffentlicht: (2025)

Adverse events associated with benznidazole treatment for Chagas disease in children and adults
von: Cintia Valeria Cruz, et al.
Veröffentlicht: (2024)

Chikungunya virus‐induced persistent allodynia is accompanied by joint microenvironmental changes and involves cartilage degradation and TRPA1 activation
von: Liziane C. M. da Silva, et al.
Veröffentlicht: (2026)

The longitudinal association between anticholinergic burden and cognitive‐functional decline among older adults
von: Etwal Bou Raad, et al.
Veröffentlicht: (2026)

Randomised, phase 1 evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of iptacopan in healthy volunteers
von: Irina Baltcheva, et al.
Veröffentlicht: (2026)

MicroRNA‐guided drug discovery for mitigating persistent pulmonary complications in critical COVID‐19 survivors: A longitudinal pilot study
von: María C. García‐Hidalgo, et al.
Veröffentlicht: (2024)

Pharmacological and behavioural effects of tryptamines present in psilocybin‐containing mushrooms
von: Ryan J. Rakoczy, et al.
Veröffentlicht: (2024)

EXPRESSION OF CONCERN: Rosiglitazone and 15‐deoxy‐Δ 12,14 ‐prostaglandin J 2 , ligands of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ), reduce ischaemia/reperfusion injury of the gut
Veröffentlicht: (2024)

Semaglutide use is associated with neuromuscular junction degradation in older adults with type II diabetes mellitus
von: Rizwan Qaisar, et al.
Veröffentlicht: (2025)

S1P/S1PRs‐TRPV4 axis is a novel therapeutic target for persistent pain and itch in chronic dermatitis
von: Xinyu Zhang, et al.
Veröffentlicht: (2024)

Estimation of ganciclovir exposure by machine learning
Veröffentlicht: (2024)

RETRACTION: Pyrrolidine Dithiocarbamate Attenuates the Development of Acute and Chronic Inflammation
Veröffentlicht: (2024)

The association between use of proton pump inhibitors and frailty index among middle‐aged and older adults
von: Rui Wu, et al.
Veröffentlicht: (2024)

Down‐regulation of M 6 A demethylase ALKBH5 facilitates morphine tolerance via SGK1 in mice
von: Yufei Shi, et al.
Veröffentlicht: (2026)

Aromatase inhibitors induce pain‐like musculoskeletal symptoms in mice: behavioural, pharmacological and pathophysiological characterization
von: Martial Caillaud, et al.
Veröffentlicht: (2026)

Clinical pharmacology in adolescent transgender medicine
von: Lauren R. Cirrincione, et al.
Veröffentlicht: (2024)

Monovalent mannose‐glycoconjugates of sulforaphane reprogram human dendritic cells via NFATc1 to induce immune tolerance under inflammatory conditions
von: María Elena Angarita‐Planchez, et al.
Veröffentlicht: (2025)

The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat
von: Chandrali S. Bhattacharya, et al.
Veröffentlicht: (2024)

Sex‐specific behavioural, metabolic, and immunohistochemical changes after repeated administration of the synthetic cannabinoid AKB48 in mice
von: Giorgia Corli, et al.
Veröffentlicht: (2024)

Schedule‐dependent neuroprotection by pioglitazone in a novel model of α‐synucleinopathy in rats: Integrated behavioural and histological outcomes
von: Alberto Santiago‐Balmaseda, et al.
Veröffentlicht: (2026)

The persistence of chronic opioid use in patients with inflammatory bowel disease—A nationwide cohort study
von: Bente Mertz Nørgård, et al.
Veröffentlicht: (2025)

Activation of M4 muscarinic receptors in the striatum reduces tic‐like behaviours in two distinct murine models of Tourette syndrome
von: Roberto Cadeddu, et al.
Veröffentlicht: (2024)

Longitudinal monitoring of cabotegravir and rilpivirine exposure from hair strand concentrations
von: E. Rosen, et al.
Veröffentlicht: (2025)

Recurrent fexuprazan‐induced liver injury following unintentional re‐exposure
von: Sook Jin Seong, et al.
Veröffentlicht: (2025)

Spotlight commentary: Addressing the persistent problem of benzodiazepine overuse, time for clinical, educational and AI‐driven reform
von: Jakša Vukojević, et al.
Veröffentlicht: (2025)

Ayahuasca‐enhanced extinction of fear behaviour: Role of infralimbic cortex 5‐HT2A and 5‐HT1A receptors
von: Isabel Werle, et al.
Veröffentlicht: (2024)

Vortioxetine reduces the development of pain‐related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down‐regulation
von: Maja Tomić, et al.
Veröffentlicht: (2024)

Correction to “Hippocampal α7 nicotinic ACh receptors contribute to modulation of depression‐like behaviour in C57BL/6J mice”
Veröffentlicht: (2025)

Comment on ‘Spotlight commentary: Addressing the persistent problem of benzodiazepine overuse, time for clinical, educational and AI‐driven reform’
von: Jennifer Koenig, et al.
Veröffentlicht: (2026)

A physiological approach to renal clearance: From premature neonates to adults
von: Nick Holford, et al.
Veröffentlicht: (2024)

The association of pain impact and sleep disruption with opioid withdrawal during opioid‐use disorder treatment
von: Jennifer D. Ellis, et al.
Veröffentlicht: (2024)

Clinical outcomes associated with ACE inhibitors and ARBs use in adults older than 85 years who recovered from dialysis‐requiring acute kidney injury
von: Jui‐Yi Chen, et al.
Veröffentlicht: (2025)

SCA44‐ and SCAR13‐associated GRM1 mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms
von: Yuyang Wang, et al.
Veröffentlicht: (2024)